President & CEO, Abeona Therapeutics
Tim Miller, Ph.D. became President and Chief Executive Officer and Director in early 2015. Dr. Miller was President & CEO of Abeona Therapeutics LLC from 2013 to 2015. He has 18 years of scientific research, product development and clinical operations expertise, with a focus on transitioning novel biotherapeutics through pre-‐clinical phases and into Phase 1 and 2 human clinical trials. Dr. Miller was President & CEO of Red5 Pharmaceuticals from 2013 until 2015 and was CEO-‐in-‐Residence at BioEnterprise Inc in 2015. He was Senior Director of Product Development at SironRX Therapeutics from 2010 to 2013. Between 1996 and 2010 Dr. Miller held various positions at several biotech companies focusing on gene therapy and regenerative medicine. Dr. Miller earned his Ph.D in Pharmacology with a focus on Gene therapy/Cystic Fibrosis from Case Western University. He also holds a B.S. in Biology and M.S. in Molecular Biology from John Carroll University (Cleveland, OH).
He has raised over $70M for therapies in cystic fibrosis, cardiovascular disease, wound healing, scar prevention, and rare diseases to advance these therapies into clinical trials. As a serial entrepreneur, he has managed all aspects of research and development, manufacturing of biologics, and clinical program start-‐up in both public and private companies, with direct experience engaging Food and Drug Administration (FDA) and NIH advisory agencies on multiple Investigational New Drug (IND) submissions. During his career, he has contributed to multiple patent applications, managed intellectual property, and published research in several internationally recognized journals. Dr. Miller received a Ph.D in Pharmacology from Case Western Reserve University and a B.S. and M.S. from John Carroll University.